Skip to content
The Nexus
DossierENTITY

Regeneron Pharmaceuticals Inc.

Coverage of Regeneron Pharmaceuticals Inc. in the Nexus archive.

Earliest in view: Apr 23 · 20:10 UTCMost recent: Apr 23 · 20:10 UTC
Co-mentioned in this coverage
Donald J. Trumpperson1White Houseorganization1most favored nation plantopic1U.S. drug pricestopic1
Recent coverage
  • POLITICSApr 23 · 20:10 UTCTHE HILL
    Trump unveils Regeneron deal to lower drug prices

    President Trump announced a voluntary price-cutting agreement with drugmaker Regeneron under the White House’s 'most favored nation' plan to align U.S. drug costs with those of other developed nations. Regeneron will reduce prices for its current and future medications sold in the U.S.

Regeneron Pharmaceuticals Inc. · Dossier · The Nexus